HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Riccardo Danielli Selected Research

EAP protocol

10/2013Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Riccardo Danielli Research Topics

Disease

21Melanoma (Melanoma, Malignant)
12/2019 - 12/2004
17Neoplasms (Cancer)
03/2021 - 12/2004
4Testicular Neoplasms (Testicular Cancer)
03/2013 - 12/2004
3Neoplasm Metastasis (Metastasis)
12/2020 - 08/2015
3Mesothelioma
02/2020 - 03/2013
3Renal Cell Carcinoma (Grawitz Tumor)
12/2018 - 03/2013
3Malignant Mesothelioma
01/2018 - 10/2013
2Prostatic Neoplasms (Prostate Cancer)
12/2020 - 12/2017
2Disease Progression
08/2015 - 04/2015
1Grover's disease
01/2022
1COVID-19
03/2021
1Drug-Related Side Effects and Adverse Reactions
12/2020
1Porokeratosis (Palmoplantar Porokeratosis)
07/2019
1Hypophysitis
12/2017
1Brain Neoplasms (Brain Tumor)
01/2017
1Sarcoma (Soft Tissue Sarcoma)
03/2013
1Uveal melanoma
01/2012
1Thrombocytopenia 1
01/2012
1Diarrhea
01/2012

Drug/Important Bio-Agent (IBA)

11IpilimumabIBA
12/2020 - 08/2009
8Monoclonal AntibodiesIBA
01/2018 - 08/2009
6AntigensIBA
02/2020 - 12/2004
6tremelimumabIBA
02/2020 - 10/2010
6AntibodiesIBA
01/2018 - 10/2010
4Proteins (Proteins, Gene)FDA Link
02/2020 - 03/2013
4DNA (Deoxyribonucleic Acid)IBA
12/2019 - 10/2005
4Immune Checkpoint InhibitorsIBA
09/2019 - 06/2015
3NivolumabIBA
01/2022 - 06/2015
3Biomarkers (Surrogate Marker)IBA
02/2020 - 01/2017
3CytokinesIBA
09/2019 - 01/2015
2ThymosinIBA
03/2021 - 10/2012
2B7-H1 AntigenIBA
02/2020 - 06/2015
2durvalumabIBA
02/2020 - 01/2018
2guadecitabineIBA
12/2019 - 03/2013
2Interleukin-2 (IL2)IBA
09/2019 - 08/2015
2Dacarbazine (DIC)FDA LinkGeneric
09/2019 - 10/2012
2atezolizumabIBA
12/2018 - 01/2018
2Bevacizumab (Avastin)FDA Link
12/2018 - 01/2018
2Sunitinib (Sutent)FDA Link
12/2018 - 01/2018
2PlatinumIBA
04/2015 - 10/2013
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2012 - 10/2005
2Histones (Histone)IBA
06/2010 - 10/2005
1Docetaxel (Taxotere)FDA Link
12/2020
1Apoptosis Regulatory ProteinsIBA
02/2020
1dehydroacetic acid (DHAS)IBA
12/2019
1Fibronectins (Fibronectin)IBA
09/2019
1ThymalfasinIBA
01/2018
17- iodo- 8- hydroxy- 3- methyl- 1- (4- azidophenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepineIBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1LigandsIBA
01/2017
1micaIBA
01/2017
1BMS-936559IBA
06/2015
1antineoplaston A10 (A 10)IBA
03/2013
1Cytidine DeaminaseIBA
03/2013
1Messenger RNA (mRNA)IBA
03/2013
1Histocompatibility Antigens Class IIBA
03/2013
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
03/2013
1Peptides (Polypeptides)IBA
12/2012
1Cancer VaccinesIBA
12/2012
1Therapeutic UsesIBA
10/2012
1Interferon-alpha (Interferon Alfa)IBA
10/2012
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2012
1SteroidsIBA
01/2012
1Alanine (L-Alanine)FDA Link
01/2012
1MicroRNAs (MicroRNA)IBA
06/2010
1DecitabineFDA Link
12/2004

Therapy/Procedure

10Immunotherapy
02/2020 - 12/2004
9Therapeutics
12/2017 - 08/2009
4Drug Therapy (Chemotherapy)
01/2018 - 08/2009
1Radiotherapy
12/2020
1Castration
12/2020
1Intralesional Injections
08/2015
1EAP protocol
10/2013